- Prohibition Partners analyses how COVID-19 might affect consumer behaviour.
- US regulators confirm cannabis businesses are ineligible for COVID-19 relief funds.
- The legal cannabis industry sees record sales as customers stockpile.
- Cannabis home deliveries soar following social distancing measures.
- Home Office signs agreement to protect UK patient access during COVID-19.
- Ohio rejects proposed amendment on recreational cannabis legalisation.
- COVID-19 may delay Maine’s recreational-cannabis market launch beyond June, 2020.
- Multiple states plan to keep dispensaries open during local lockdown measures.
- New federal data shows a drop in federal prosecutions for cannabis offences.
PROHIBITION PARTNERS LIVE
Prohibition Partners LIVE will be the largest cannabis event in the world this summer. We are taking our industry-leading conferences online, delivering you agenda-setting content, targeted virtual networking and engaging digital experiences. All at the touch of a button.
As of 27 March, we have seen over 530,000 confirmed cases of coronavirus (COVID-19) across 199 countries. As the outbreak develops, Prohibition Partners is monitoring the situation and reporting on the probable impacts for the nascent cannabis industry.
Last week we reviewed what a global recession would mean for the industry, how the CBD industry could fare during the pandemic and how public attitudes might shift in response to the outbreak. This week we review the extent to which different consumer groups might change their behaviours, as well as the potential broader implications for the industry.
PSYCH: The Psychedelics as Medicine Report
Read the stories that shape the cannabis industry
Canadian cannabis sales grew by 19% month-on-month to reach new record in March. Czech government approves...
USDA rules hemp farmers ineligible for COVID-19 relief funds. South Korea’s sovereign wealth fund buys into Canadian...
Artemis Growth Partners acquires UK cannabis producer Bridge Farm for US$81 million. Lockdown measures are fuelling...